Guiding abx prescription by matching the infecting bug with the correct drug by combining #moleculardiagnostics with epidemiological surveillance and big-data.
ID Genomics, SPC, is offering rapid sequencing of key genomic regions of SARS-CoV-2 able to differentiate thousands of currently circulating variants, including multiple sub-variants of the Omicron, Delta and other variants.
November 18-24, 2021 is U.S. Antibiotic Awareness Week.
ID Genomics is committed to fight antibiotic resistance by developing precision diagnostic tests to guide antibiotic choices
Please visit our website to know more
https://t.co/B7CVUiR57U
ID Genomics, SPC, is in the process of launching a next-day cost-effective service to identify all SARS-CoV-2 variants currently being monitored– Delta, Mu, Gamma, Epsilon, Iota, etc - and hundreds of their structural and nonstructural subvariants.
We are excited to be on the news!!
"Alongside Seattle-based ID Genomics, which Sokurenko founded, the professor’s laboratory is leading the creation and future implementation of a new method to “fingerprint” all currently known variants."
https://t.co/cTNjpGfIV5
We are thrilled to announce that we received Phase I STTR grant from National Institutes of Health (NIH) entitled “Rapid Genetic Fingerprinting of SARS-Cov-2 Variants”
#covid#sars-cov-2 #variants#fingerprinting
https://t.co/fHTzYHywNa
The perfect storm - COVID-19 underscores the need to be prepared for the next pandemic, and the pressing need for vaccines, diagnostics, antibiotics and other therapeutics to address bacterial infections and AMR. https://t.co/0ZX91GiBO9
Epidemiological surveillance database BactNeT developed at IDG, is a perfect tool for hospital Antibiotic Stewardship programs. https://t.co/xjhl17qlyO
#USAAW19#BeAntibioticsAware
#Antibiotics are one of the most powerful tools we have to fight infections. But they can cause side effects and can lead to #AntibioticResistance. This #USAAW19, learn more about when abx are and aren’t needed so you can #BeAntibioticsAware. https://t.co/OaxFhBAfGh
IDG Team is proud to announce the completion of the first Pre-Submission meeting with the FDA for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs).
https://t.co/5bss76JOup
Simple infections become more resistant to antibiotics. IDGenomics develops a rapid diagnostic test to detect UTI pathogen, predict its antibiotic susceptibility in under an hour for a more precise antibiotic prescription.
https://t.co/m9NH30hitT